As of 2025-07-15, the Intrinsic Value of Newscope Capital Corporation (PHRM.CN) is -0.08 CAD. This PHRM.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.45 CAD, the upside of Newscope Capital Corporation is -118.55%.
Based on its market price of 0.45 CAD and our intrinsic valuation, Newscope Capital Corporation (PHRM.CN) is overvalued by 118.55%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -0.08 - -0.08 | -0.08 | -118.55% |
| P/E | (0.01) - (0.10) | (0.01) | -102.4% |
| DDM - Stable | (0.35) - 4.39 | 2.02 | 349.3% |
| DDM - Multi | (0.42) - 4.05 | (0.92) | -305.5% |
| Market Cap (mil) | 39.83 |
| Beta | 0.66 |
| Outstanding shares (mil) | 88.52 |
| Enterprise Value (mil) | 38.61 |
| Market risk premium | 5.10% |
| Cost of Equity | 5.51% |
| Cost of Debt | 5.00% |
| WACC | 4.60% |